- Home
- BTMD vs CSBR Comparison
BTMD vs CSBR Comparison
Compare BTMD & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTMD
- CSBR
- Stock Information
- Founded
- BTMD 2012
- CSBR 1985
- Country
- BTMD United States
- CSBR United States
- Employees
- BTMD N/A
- CSBR N/A
- Industry
- BTMD Medicinal Chemicals and Botanical Products
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BTMD Health Care
- CSBR Health Care
- Exchange
- BTMD Nasdaq
- CSBR Nasdaq
- Market Cap
- BTMD 136.0M
- CSBR 135.5M
- IPO Year
- BTMD N/A
- CSBR 1986
- Fundamental
- Price
- BTMD $3.36
- CSBR $8.17
- Analyst Decision
- BTMD Strong Buy
- CSBR Strong Buy
- Analyst Count
- BTMD 1
- CSBR 1
- Target Price
- BTMD $8.00
- CSBR $12.00
- AVG Volume (30 Days)
- BTMD 324.0K
- CSBR 48.4K
- Earning Date
- BTMD 05-06-2025
- CSBR 03-11-2025
- Dividend Yield
- BTMD N/A
- CSBR N/A
- EPS Growth
- BTMD N/A
- CSBR N/A
- EPS
- BTMD 0.09
- CSBR 0.46
- Revenue
- BTMD $197,191,000.00
- CSBR $58,591,000.00
- Revenue This Year
- BTMD $6.20
- CSBR $15.11
- Revenue Next Year
- BTMD $9.24
- CSBR $7.80
- P/E Ratio
- BTMD $37.44
- CSBR $19.35
- Revenue Growth
- BTMD 6.38
- CSBR 19.03
- 52 Week Low
- BTMD $3.04
- CSBR $3.60
- 52 Week High
- BTMD $8.44
- CSBR $11.99
- Technical
- Relative Strength Index (RSI)
- BTMD 37.19
- CSBR 36.81
- Support Level
- BTMD $3.21
- CSBR $9.21
- Resistance Level
- BTMD $3.65
- CSBR $9.97
- Average True Range (ATR)
- BTMD 0.28
- CSBR 0.67
- MACD
- BTMD -0.01
- CSBR -0.13
- Stochastic Oscillator
- BTMD 11.90
- CSBR 5.45
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.